Consultant-Led Radiation Therapy Plan Peer Review Meeting and Improved Access to and Outcomes From Curative Intent Lung Cancer Radiation Therapy. by Hanna, Gerard et al.
Consultant-Led Radiation Therapy Plan Peer Review Meeting and
Improved Access to and Outcomes From Curative Intent Lung
Cancer Radiation Therapy.
Hanna, G., Johnston, R. E., Eakin, R. L., Harney, J., Rooney, K. P., Young, L., & McAleese, J. (2016).
Consultant-Led Radiation Therapy Plan Peer Review Meeting and Improved Access to and Outcomes From
Curative Intent Lung Cancer Radiation Therapy.. E466. Poster session presented at Boston Convention and
Exhibition Center, Boston, United States.DOI: 10.1016/j.ijrobp.2016.06.1800
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
Copyright 2016 The Authors
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:15. Feb. 2017
Consultant-led radiotherapy plan peer review meeting and improved 
access to and outcomes from curative intent lung cancer radiotherapy.
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Purpose:
Our centre introduced consultant (Attending Physician) led peer review of all curative intent lung
cancer (NSCLC and SCLC) radiotherapy plans in 2011. In this process, all components of the
treatment pathway, including decision to treat, target volume delineation, radiotherapy plan
coverage and proposed image guidance are discussed and the meeting recommendations are
recorded on a database. We have previously demonstrated a significant impact on radiotherapy
plan target volume delineation. Given this impact we seek to assess the clinical impact of
introducing a consultant led radiotherapy plan peer review process.
Methods:
Using our institutional lung cancer radiotherapy database we identified all patients with NSCLC and
SCLC who had curative intent radiotherapy between 2001 and 2015. Using our regional cancer
clinical database and cancer registry figures we identified the total number of patients diagnosed
with lung cancer. Using these sources, we recorded the proportion of all patients with a lung cancer
diagnosis who received curative intent radiotherapy and for the patients who received curative
intent radiotherapy, the 90-day mortality and the 2-year overall survival. Survival was estimated
using the Kaplan Meier method.
Results:
In total 1096 patients were treated with curative intent radiotherapy between 2001 and 2015 in our
region. During this time period, there was an increase in the proportion of patients with lung cancer
receiving radiotherapy from 5% (95% C.I. 4.6% to 5.4%) before 2011 to 10% (95% C.I. 9.2% to
10.8%) after 2011. This increase was seen across the region. The 90 day mortality rate remained
relatively stable 3% versus 4% (NS). Although other factors need to be taken in to account the 2-
year overall survival increased from 39% to 46% (HR 0.86 – 95% C.I. =0.70 to 0.97).
Conclusions:
There has been a doubling of the use of radical radiotherapy, without an increase in short term
mortality or a fall in survival which has coincided with the establishment of a regional lung cancer
radiotherapy peer review meeting. We propose that peer review is a significant factor in increasing
access to and outcomes from curative intent lung cancer radiotherapy.
• Using our institutional lung cancer
radiotherapy database we identified all
patients with NSCLC and SCLC who had
curative intent radiotherapy between 2001
and 2015.
• Using our regional cancer clinical database
and cancer registry figures we identified the
total number of patients diagnosed with lung
cancer.
• Using these sources, we recorded the
proportion of all patients with a lung cancer
diagnosis who received curative intent
radiotherapy and for the patients who
received curative intent radiotherapy, the 90-
day mortality and the 2-year overall survival.
• Survival was estimated using the Kaplan
Meier method.
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• Our centre introduced consultant (Attending Physician)
led peer review of all curative intent lung cancer
(NSCLC and SCLC) radiotherapy plans in 2011.
• In this process, all components of the treatment
pathway are discussed and the meeting
recommendations are recorded on a database (see
figure 1) and these, include:
 decision to treat;
 target volume delineation;
 radiotherapy plan coverage;
 proposed image guidance.
• We have previously demonstrated a significant impact
on radiotherapy plan target volume delineation1.
• Given this impact we seek to assess the clinical impact




 In the study period, there has been a doubling of the use of radical radiotherapy,
without an increase in short term mortality or a fall in survival.
 This has coincided with the establishment of a regional lung cancer radiotherapy
peer review meeting.
 We suggest that peer review is a significant factor in increasing access to and
outcomes from curative intent lung cancer radiotherapy.
Fig 1: Recording fields for the Northern Ireland radical 
lung radiotherapy peer review database
• In total 1096 patients were treated
with curative intent radiotherapy
between 2001 and 2015.
• During this time period, there was an
increase in the proportion of patients
with lung cancer receiving
radiotherapy from 5% (95% C.I. 4.6%
to 5.4%) before 2011 to 10% (95%
C.I. 9.2% to 10.8%) after 2011.
• This increase was seen across the
region.
• 90-day mortality rate remained
relatively stable 3% versus 4% (NS).
• Although other factors need to be
taken in to account the 2-year overall
survival increased from 39% to 46%
(HR 0.86 – 95% C.I. =0.70 to 0.97).
Fig 2: Overall 
survival before and 
after introduction of 
peer review
Fig 3: Northern 
Ireland curative intent 
radiotherapy for lung 
cancer access rates 
from 2011 to 2015.
